Good overview of drug discovery process and steps to take a new drug to the clinic!

🌱 Tetra Bio-Pharma executives speak out about building a cannabinoid pharmaceutical company. Find out more from Jean-François Boily, Steeve Néron, and Dr Melanie Kelly. Downwards arrow #Cannabinoids #Pharmaceuticals #DrugInnovation healtheuropa.eu/innovation-and…

Until a Vaccine Arrives, a Worrisome Road Ahead nytimes.com/2020/11/13/ins…

Thx to @gameplandematch I met Segun Makinde and recently had the pleasure of joining the Inner Olympian podcast. We talked about about: ✔️transformative power of sport ✔️value of mentorship ✔️separating identity from performance ✔️showing up for yourself anchor.fm/theinnerolympi…

Tetra Bio-Pharma’s Tetra Bio-Pharma drug ARDS-003 has been cleared by the FDA for human trials to target sepsis and ARDS. #COVID19 #Inflammation #DrugDevelopment healtheuropa.eu/a-novel-treatm…

CB2 Therapeutics is a strategic joint venture between Thorne & Tetra Bio-Pharma. We are happy to share that we have been granted a #USA patent this week for the treatment of interstitial cystitis. #partnership #cannabinoids $TBP $TBPMF

Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial finance.yahoo.com/news/tetra-bio… via Yahoo

Happy to see this amazing product available to order. Great service already received my supply ordered less than a week ago - awaye.ca/?fbclid=IwAR2D…

There remains a need for #safe, #effective & non-addictive alternatives to #opioids. This article in BIOTECanada features Tetra's leadership role in creating #cannabinoid-based drugs in the fight against the #opioidcrisis. Pages 76-77 $TBP $TBPMF bit.ly/3gFrdam

Mark your calendars for the 2022 Cannabinoids in Clinical Practice hybrid conference on April 21-22! We are proud to be co-hosting this year's event with Toronto Cannabis & Cannabinoid Research Consortium ! #CCIC2022 Register for in-person or virtual attendance. More details here: ccic.net/ccic-conferenc…

We're proud to be part of the 2nd #ARDS Drug Development Summit in #Boston. Our very own R&D Program Director, Dr. Erin Bassett, will be speaking on July 14 on Divulging ARDS Preclinical & Clinical Regulatory Experiences. Agenda & registration details: ards-summit.com.

Kayle Dickson from the Lehmann lab presents her research at #icrs2022galway showing efficacy of terpenes for bladder health

In honour of Mary Abood, an CannabinoidSociety "Women in Cannabinoid Research Fund" has been established to support women in the field be a part of the community. Please contribute if you can. icrs.co/INMEMORIAM/Mar… icrs.co/MaryEAbood.ICR…

thecannabisscientist.com/business-profe…

icrs2023.org

thecannabisscientist.com/research-devel…

There's still time to join us in-person in Toronto for ICRS2023 – or virtually! Hundreds of #cannabinoid science presentations at this year's Symposium. Join us – June 24-29 in Toronto! #ICRS2023TORONTO #ICRS2023 ICRS.com ICRS2023.org

Dr. Lauren Kelly kicked off the CannabinoidSociety Pediatrics Special Interest Group Meeting by sharing some exciting updates from C4T! 🥳 Stay tuned for our keynote speaker Dr. Elizabeth Thiele!

a fantastic roster of speakers at #C4T SIG meeting at #ICRS2023

A really clear presentation by @TrinityLFencing MedCannKids Research SIG ⁦CannabinoidSociety⁩ #ICRS2023 meeting on the value of youth engagement in pediatric medical cannabis CT